EMF intolerance:a physical illness

[Guest guest]

Prof. Dominique Belpomme, Oncologist,

Professor of the Centre Hospitalier Universitaire Necker-Enfants Malades,

Chairman of Research for Anti-Cancer Therapeutics (ARTAC), in his lecture

“Diagnostic and Therapeutic Protocols for Electromagnetic Fields Intolerance”,

showed the results of a clinical observation on more than 450 patients enrolled

from 2008 to 2011. He and his team use a new technique to make the diagnosis to

people reporting reactions to electromagnetic fields, a condition that he prefers

to define as “Electromagnetic Fields Intolerance” or “EFI

Syndrome” rather than “Electromagnetic Hyper-Sensitivity”.

The new technique is the “Pulsed

Eco-Doppler” of the brain that combines the eco-doppler with a computer

to evaluate brain perfusion. Unlike some other methods, this one is not

dangerous and it does not involve any ionizing radiation. The results show that

people with Electromagnetic Fields Intolerance have a reduced perfusion in the

brain, particularly in the left part of the limbic area of the brain, compared

to the control group. This is a very particular area, because it is the

“ancient” part of the brain that controls many body functions.

“These results are very important

– Belpomme said at the congress – because for the first time we are

able to define the Electromagnetic Fields Intolerance as a physical illness

based on objective tests”.

His team uses also other tests, such as the

dosage of histamine, of protein S100B, and of heat shock proteins hsp70 and

hsp27 in the blood. The 70% of the group of patients observed showed a serious

reduction of vitamin D, about 1-2% of the patients showed an increase of

proteins hsp27 and hsp70, while more than the 40% of the sample had increased

histamine, a fact that is fully compatible with a physiological interpretation

of this syndrome.

About 10% of the patients had an increased

protein S100B, which is a marker for Blood Brain Barrier (BBB) permeability. In

one third of the sample, a reduction of melatonin in urine was found, and this

can explain symptoms such as fatigue, insomnia and depression in these

patients.

These alterations are quite similar to the

ones found in patients with Multiple

Chemical Sensitivity (MCS), particularly regarding the brain

perfusion reduction, the neurogenic inflammation, the oxidative stress

increase, and the reduction of the defense mechanism. The fact that EMF induces

the opening of the BBB may interfere with the brain protection from toxic chemicals.

It is not uncommon, in fact, that patients with EFI Syndrome have MCS symptoms,

while many patients with MCS also react to EMF.

1 of 1 File(s)

_Certification_.txt